Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells
Corticoid-induced osteonecrosis (ON) of femoral head can lead to severe hip joint impairment and hip replacement, with negative impact in young survivors of acute lymphoblastic leukaemia (ALL) with long life expectancy. We aim to improve quality of life in these patients with a novel approach.
Based on the regenerative capacities of mesenchymal stem cells (MSCs), we performed locally implanted autologous cell therapy in two adolescents suffering of bilateral femoral ON. This required a simple, minimally invasive surgical procedure.
Both patients experienced significant pain relief and restoration of gait kinematic values. Radiographic evaluation showed cessation of hip collapse. No toxicities/complications were observed after a 4-year follow-up.
Our preliminary results suggest that autologous MSCs can be considered as a novel treatment for children and young adults with ON after overcoming ALL. It may avoid hip replacement and improve quality of life of leukaemia survivors.
KeywordsOsteonecrosis Necrosis of the femoral head Acute lymphoblastic leukaemia Children Mesenchymal stem cells Cell therapy
This work was supported by a grant from the Madrid Regional Government (P2010/BMD-2420, CellCAM) to MR.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments and comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 3.Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, et al. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol. 2014;36:22–9.CrossRefPubMedGoogle Scholar
- 17.Martinez-Laperche C, Gomez-Garcia AM, Lassaletta A, Moscardo C, Vivanco JL, Molina J, et al. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol. 2013;88:359–64.CrossRefPubMedGoogle Scholar
- 26.Gianakos AL, Moya-Angeler J, Duggal S, Zambrana L, Fields KG, Mintz DN, et al. The efficacy of bisphosphonates with core decompression and mesenchymal stem cells compared with bisphosphonates alone in the treatment of osteonecrosis of the hip: a retrospective study. HSSJ. 2016;12:137–44.CrossRefGoogle Scholar
- 28.Tomaru Y, Yoshioka T, Sugaya H, Aoto K, Wada H, Akaogi H, et al. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively. BMC Musculoskeletal Disord. 2017;18:292.CrossRefGoogle Scholar
- 30.Gadji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;46(5):1005–9.Google Scholar
- 33.Ma Y, Wang T, Liao J, Gu H, Lin X, Jiang Q, et al. Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head: a prospective, double blinded, randomized, controlled study. Stem Cell Res Ther. 2014;5(5):115.CrossRefPubMedPubMedCentralGoogle Scholar